Why InvoCare and these ASX shares just stormed to 52-week highs

The InvoCare Limited (ASX:IVC) share price is one of three charging to new highs this week. Here's why…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

The Australian share market has been on fire this month, rising to a multi-year high thanks partly to the Federal election result.

Unsurprisingly, this has led to a number of shares storming to 52-week highs or better. Three that achieved this are listed below. Here's why they are flying high:

The Audinate (ASX: AD8) share price reached an all-time high of $7.49 on Wednesday. Investors have been fighting to get hold of the shares of the leading provider of digital Audio-Visual networking technologies due to the success of its Dante audio over IP networking solution. Dante is an uncompressed, multi-channel digital media networking technology, with near-zero latency and synchronisation. The quality of the product has led to Dante quickly becoming the industry's preferred audio networking solution. At the last count the product had been adopted by more pro-audio AV manufacturers than any other networking technology.

The InvoCare Limited (ASX: IVC) share price climbed to a 52-week high of $16.08 yesterday. The funerals company's shares have been on a solid run since the release of first quarter update earlier this month which revealed that trading conditions have improved this year. In addition to this, a particularly severe flu season appears to have caught the eye of investors and could (unfortunately) mean increased demand for its funeral services.

The Next Science Ltd (ASX: NXS) share price raced to a new all-time high of $2.49 on Wednesday. This means that the recently listed medical technology company's shares have risen 149% since hitting the ASX boards at $1.00 per share last month. Investors appear to believe that the company's chronic wound treatment technology has a lot of potential. Next Science has four FDA cleared products currently available in the U.S. market to treat and manage surgical site infections and chronic wounds.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended AUDINATEGL FPO. The Motley Fool Australia has recommended InvoCare Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on 52-Week Highs

A man in a supermarket strikes an unlikely pose while pushing a trolley, lifting both legs sideways off the ground and looking mildly rattled with a wide-mouthed expression.
Consumer Staples & Discretionary Shares

Woolworths shares soar to new multi-year high: Buy, sell or hold?

After a bumpy start to the year, the supermarket giant's shares are back in favour with investors.

Read more »

a person stands arms outstretched on the top of a mountain with a beautiful sunrise in the sky
52-Week Highs

3 ASX 200 shares, including Macquarie and BHP, smashing new 52-week-plus highs today

Investors just sent Macquarie, BHP, and this top ASX 200 share to new one-year-plus highs. But why?

Read more »

A young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
52-Week Highs

This ASX tech stock just hit a 52-week high after soaring 35% in a month

Investors have sent this ASX tech share to a yearly high.

Read more »

Children skipping and jumping up a hill.
52-Week Highs

QBE shares just hit a decade high. Is it too late to buy?

QBE shares just hit decade highs after a strong start to 2026.

Read more »

A team of people giving the thumbs up sign.
52-Week Highs

Transurban, Aurizon, Ampol shares hit fresh multi-year highs: Buy, sell or hold today?

These ASX 200 shares have significantly outpaced the index so far in 2026.

Read more »

Hand of a woman carrying a bag of money, representing the concept of saving money or earning dividends.
52-Week Highs

Can these ASX shares hitting 52-week highs keep rising?

It could be time to take profits on these winning stocks.

Read more »

An older couple enjoying their retirement come together in their warm heated home with fire cracker sparklers.
52-Week Highs

These ASX stocks have hit the ground running in June – can they keep rising?

Where to next for these red hot shares?

Read more »

A young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
52-Week Highs

3 top ASX shares at 52-week highs I'd still buy

A 52-week high should not automatically scare investors away if the business still has room to improve over time.

Read more »